Menlo Park-based Sight Science boosts IPO targets by 57%

Sight Sciences Inc. boosted by 57% how much it plans to raise this week in an initial public offering that could give it a valuation of more than $1 billion. The Menlo Park medical device maker now plans to raised up to $276 million in an offering that is expected to price later in the day ahead of its Wall Street debut Thursday. Sight Sciences expects to sell 10 million shares for between $23 and $24 each. It previously planned to offer 7 million sha res for between $20 and $23. Another 1.5 million…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news